ARROWHEAD 13G

Company

ARROWHEAD PHARMACEUTICALS, INC.

Filed

February 12, 2014

Accession Number

0001044321-14-000027

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →